| Issue Date | Title | Author(s) |
| 2022-12-13 | Polysaccharide-Based Nanomedicines Targeting Lung Cancer | Bhat, AA; Gupta, G; Alharbi, KS; Afzal, O; Altamimi, ASA; Almalki, WH; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Chellappan, DK; Singh, SK; MacLoughlin, R; Oliver, BG; Dua, K |
| 2022-11-22 | Role of flavonoids in management of various biological targets in Alzheimer's Disease: evidence from preclinical to clinical studies. | Alharbi, KS; Javed Shaikh, MA; Imam, SS; Alshehri, S; Ghoneim, MM; Almalki, WH; Singh, SK; Kumar, D; Kumar, AP; Dua, K; Chellappan, DK; Paudel, KR; Gupta, G |
| 2022-10 | Oligonucleotides: A novel area of interest for drug delivery in neurodegenerative diseases | Alharbi, KS; Javed Shaikh, MA; Afzal, O; Alfawaz Altamimi, AS; Hassan almalki, W; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Babu, MR; Singh, SK; Chellappan, DK; Dua, K; Gupta, G |
| 2022-09-15 | Molecular explanation of Wnt/βcatenin antagonist pyrvinium mediated calcium equilibrium changes in aging cardiovascular disorders. | Alharbi, KS; Singh, Y; Afzal, O; Alfawaz Altamimi, AS; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Chellappan, DK; Singh, SK; Dua, K; Gupta, G |
| 2022-08 | Biochemical interaction of pyrvinium in gentamicin-induced acute kidney injury by modulating calcium dyshomeostasis and mitochondrial dysfunction | Alharbi, KS; Ali, T; Singh, Y; Ali Al-Ghamdi, AS; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Afzal, O; Alfawaz Altamimi, AS; Singh, SK; Chellappan, DK; Dua, K; Gupta, G |
| 2022-08 | An overview of epithelial growth factor receptor (EGFR) inhibitors in cancer therapy | Alharbi, KS; Javed Shaikh, MA; Afzal, O; Alfawaz Altamimi, AS; Almalki, WH; Alzarea, SI; Kazmi, I; Al-Abbasi, FA; Singh, SK; Dua, K; Gupta, G |
| 2022-06-01 | Sodium alginate based drug delivery in management of breast cancer | Shaikh, MAJ; Alharbi, KS; Almalki, WH; Imam, SS; Albratty, M; Meraya, AM; Alzarea, SI; Kazmi, I; Al-Abbasi, FA; Afzal, O; Altamimi, ASA; Singh, Y; Singh, SK; Dua, K; Gupta, G |
| 2022-06 | A narrative review on the biology of piezo1 with platelet-rich plasma in cardiac cell regeneration | Alharbi, KS; Almalki, WH; Alzarea, SI; Kazmi, I; Al-Abbasi, FA; Afzal, O; Alfawaz Altamimi, AS; Singh, SK; Dua, K; Kumar, G |
| 2022-03-21 | Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora | Alharbi, KS; Singh, Y; almalki, WH; Rawat, S; Afzal, O; Altamimi, ASA; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Singh, SK; Bhatt, S; Chellappan, DK; Dua, K; Gupta, G |
| 2022-02-25 | Synergism of CD28 Immune Molecule in Late Immunosuppressive Phase of COVID-19: Effectiveness in Vaccinated Individuals. | Alharbi, KS; Singh, Y; Prasad Agrawal, G; Altowayan, WM; Almalki, WH; Sharma, A; Singh, SK; Jha, NK; Chellappan, DK; Dua, K; Gupta, G |
| 2022-02 | Nuclear factor-kappa B (NF-κB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases | Alharbi, KS; Afzal, O; almalki, WH; Kazmi, I; Javed Shaikh, MA; Thangavelu, L; Gulati, M; Singh, SK; Jha, NK; Gupta, PK; Chellappan, DK; Oliver, BG; Dua, K; Gupta, G |
| 2022 | PI3K/Akt/mTOR Pathways Inhibitors with Potential Prospects in Non-Small-Cell Lung Cancer. | Alharbi, KS; Shaikh, MAJ; Almalki, WH; Kazmi, I; Al-Abbasi, FA; Alzarea, SI; Imam, SS; Alshehri, S; Ghoneim, MM; Singh, SK; Chellappan, DK; Oliver, BG; Dua, K; Gupta, G |
| 2021-06 | Nuclear factor-kappa B and its role in inflammatory lung disease | Alharbi, KS; Fuloria, NK; Fuloria, S; Rahman, SB; Al-Malki, WH; Javed Shaikh, MA; Thangavelu, L; Singh, SK; Rama Raju, VS; Jha, NK; Chellappan, DK; Dua, K; Gupta, G |
| 2021-03-09 | Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection | Singh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G |
| 2020-11 | Beta-catenin non-canonical pathway: A potential target for inflammatory and hyperproliferative state via expression of transglutaminase 2 in psoriatic skin keratinocyte. | Gupta, G; Singh, Y; Tiwari, J; Raizaday, A; Alharbi, KS; Al-Abbasi, FA; Kazmi, I; Satija, S; Tambuwala, MM; Devkota, HP; Krishnan, A; Chellappan, DK; Dua, K |
| - | The therapeutic role of nutraceuticals targeting the Nrf2/ <scp>HO</scp> ‐1 signaling pathway in liver cancer | Alharbi, KS; Almalki, WH; Albratty, M; Meraya, AM; Najmi, A; Vyas, G; Singh, SK; Dua, K; Gupta, G |
| - | Role of Medicinal plant‐derived Nutraceuticals as a potential target for the treatment of breast cancer | Alharbi, KS; Almalki, WH; Makeen, HA; Albratty, M; Meraya, AM; Nagraik, R; Sharma, A; Kumar, D; Chellappan, DK; Singh, SK; Dua, K; Gupta, G |
